Acquirer | Target | Price |
---|---|---|
Aspen Global Inc. | Rights to 7 anesthesia drugs | $520 million |
Zimmer Biomet | LDR Holding Corporation | $1 billion |
Premier Inc. | Lincare's specialty pharmacy business | $75 million |
Takeda Pharmaceutical Company | License to Theravance's TD-8954 | $15 million |
Merck & Co. | Afferent Pharmaceuticals | $500 million |
Meridian Behavioral Health | Valhalla Place | N/A |